Navigation Links
Andrew J. Dannenberg, M.D., honored with AACR-Prevent Cancer Foundation Award
Date:10/19/2011

PHILADELPHIA The AACR will present the 2011 AACR-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research to Andrew J. Dannenberg, M.D., at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, held Oct. 22-25, 2011. Dannenberg is director of the Weill Cornell Cancer Center and director of cancer prevention at New York-Presbyterian/Weill Cornell Medical Center. He is also the Henry R. Erle, M.D.-Roberts Family Professor of Medicine at Weill Cornell Medical College.

Dannenberg's work has provided the basis for the transformative discovery linking obesity, inflammation and breast cancer. He is recognized for his work on the inflammation-cancer connection with an emphasis on prostaglandin biology. Dannenberg's research has been of major importance in explaining why levels of procarcinogenic prostaglandins are increased in inflamed tissues and tumors. He has also made major contributions to our understanding of why nonsteroidal anti-inflammatory drugs show chemopreventive activity.

The AACR-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research is given annually for seminal laboratory, translational, clinical, epidemiological or behavioral science contributions to the field of cancer prevention.

Dannenberg's significant contributions include demonstrating that COX-2 was overexpressed in a variety of premalignant lesions and cancers; elucidating the mechanisms by which oncogenes, tumor suppressor genes, carcinogens and tumor promoters regulate COX-2 gene expression; utilizing both pharmacological and genetic strategies to establish the importance of targeting prostaglandin synthesis as a bona fide prevention strategy; defining the signal transduction pathways by which dietary and synthetic chemopreventive agents suppress COX-2 transcription and prostaglandin synthesis; and determining the signaling mechanism by which COX-derived prostaglandin E2 induced aromatase, the rate-limiting enzyme responsible for estrogen synthesis. This latter work led to an observational study in which the use of aspirin was associated with a reduced risk for hormone receptor-positive breast cancer.

In his most recent work that provides new insights into the link between obesity, inflammation and breast cancer, Dannenberg conducted a preclinical study in which he used experimental models to demonstrate the presence of the obesityinflammationaromatase axis in the mammary gland. As a result, COX-2-derived PGE2 appeared to play an important role in inducing aromatase in the mammary glands of obese mice. Subsequently, he successfully translated these preclinical findings.

Dannenberg will present his lecture, "Obesity and Breast Inflammation: Implications for Cancer Prevention," on Sunday, Oct. 23, 2011, at 5:15 p.m.


'/>"/>

Contact: Michele Sharp
Michele.Sharp@aacr.org
267-446-7156
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Cedars-Sinai Medical Center Names Beverly Hills Plastic Surgeon Dr. Andrew Cohen as Chief of the Center for Plastic and Reconstructive Surgery
2. Counseling Suicidal Clients by Andrew Reeves
3. UCSF neurologist William Seeley, M.D., named MacArthur Fellow
4. Dale Browne, M.D., ear, nose, and throat specialist, receives award from National Medical Society
5. Ching-Hon Pui, M.D., honored by the American Society of Hematology for work in childhood cancer
6. BUS Jeffrey H. Samet, M.D., selected as a 2011 NIDA International Program Awards of Excellence winner
7. Mayo Clinic: Raoul Tibes, M.D., Ph.D., to receive Career Development Award
8. BIDMCs Peter Weller, M.D., receives NIH MERIT Award
9. BIDMC neurologist Bernard Chang, M.D., receives award for epilepsy research
10. Alfred B. Knight, M.D., Scott & White Healthcare, presents at 8th Annual World Health Care Congress
11. Ching-Hon Pui, M.D., recognized with American Association for Cancer Research award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... Texas (PRWEB) , ... January 24, 2017 , ... ... year introduces more changes during the Annual Enrollment Period (AEP) and the Open ... scrambling looking for health insurance coverage. Mainly, people are witnessing higher deductibles, rising ...
(Date:1/24/2017)... ... 2017 , ... Manzo Pharmaceuticals, LLC., announced that the name ... the United States Patent and Trademark Office. The purpose of this is ... thinking that other products are similar to the patented Lacto-Freedom Probiotic. ...
(Date:1/24/2017)... ... January 24, 2017 , ... Seceon , ... threats in real-time, today announced a strategic partnership with Paramount , the ... respond and protect their critical information assets and infrastructure, in a comprehensive and ...
(Date:1/24/2017)... , ... January 24, 2017 , ... Bellus Medical, a ... team of medical experts. In his new role Dr. Dobke will provide physician oversight ... Dr. Dobke is the Head of Plastic Surgery and Associate Professor of Surgery at ...
(Date:1/24/2017)... ... , ... The University of Iowa, long recognized as one of the top ... provides teachers with the specific skills and training they need to teach English as ... students and HigherEducation.com is working to ensure that this new program is available to ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... India , Jan. 24, 2017 Market Research Future ... Integumentary System Market. The global market for Plastic Surgery & Integumentary ... by the end of the forecasted period. Market Highlights ... Global Plastic Surgery ... market and predicted that the market will reach high growth figures ...
(Date:1/24/2017)... , Jan. 24, 2017 Regeneron Pharmaceuticals, Inc. ... Public today recognized 40 finalists in the Regeneron Science ... and math competition for high school seniors. Finalists were ... of their research projects. The finalists will ... from March 9-15 to undergo a rigorous judging process ...
(Date:1/24/2017)... LONDON , January 24, 2017 Analysis ... End User Liquid Biopsies - our new study reveals ... biopsy market heading? If you are involved in this sector you ... you the potential revenues streams to 2027, assessing data, trends, opportunities ... ...
Breaking Medicine Technology: